Ranitidine Tablet
Product Images NDC 62207-773

15 FDA label images from Granules India Ltd · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Ranitidine (NDC 62207-773). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules India Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

62207-773-32.jpg (62207 773 32)

62207-773-32.jpg (62207 773 32)
Text panel for Ranitidine Tablets USP 150 mg, specifying each film-coated tablet contains Ranitidine 150 mg (as Ranitidine hydrochloride USP 168 mg). Provides batch number, manufacturing and expiration dates (placeholders), NDC number 62207-773-32, manufacturing license number, storage instructions (20°-25°C, avoid heat/humidity), and caution for repacking only. Indicates country of origin: India.*
FDA Label Image

62207-773-36-carton.jpg (62207 773 36 Carton)

62207-773-36-carton.jpg (62207 773 36 Carton)
Label for Ranitidine Tablets, USP 150 mg film-coated tablets. The label includes batch number, manufacturing and expiration dates (placeholders), NDC number 62207-773-36, manufacturing license number, and packaging details of 5x10,000 units. It advises storage at 20°-25°C (68°-77°F) away from excessive heat or humidity. The label also contains barcodes and notes the country of origin as India, with cautions for repacking only.*
FDA Label Image

62207 773 41 Carton

62207 773 41 Carton
Ranitidine cool mint 150 mg oral tablets packaging label from Granules India Ltd. The label states the product is an acid reducer used to prevent and relieve heartburn associated with acid indigestion and sour stomach. The box contains 24 tablets (24 doses). Drug facts panels with detailed usage, warnings, directions, inactive ingredients, and contact information are visible.*
FDA Label Image

62207 773 47 Carton

62207 773 47 Carton
Packaging label for Ranitidine cool mint 150 mg tablets, USP, oral acid reducer by Granules India Ltd. The label highlights the maximum strength, 500 tablets per pack, and states its use for heartburn and indigestion relief. It includes drug facts with warnings, directions, inactive ingredients, manufacturer details, and contact information.*
FDA Label Image

62207 773 58 Carton

62207 773 58 Carton
The packaging label for Ranitidine Tablets USP 150 mg, an acid reducer marketed under the proprietary name Ranitidine cool mint by Granules India Ltd. The label indicates the package contains 20 tablets (2x10) with a maximum strength of 150 mg. The label includes Drug Facts, warnings, usage instructions, and a barcode, prominently showing the NDC 62207-773-58.*
FDA Label Image

62207-774-32.jpg (62207 774 32)

62207-774-32.jpg (62207 774 32)
Ranitidine cool mint film-coated tablets, USP 150 mg oral dosage form. The label shows the active ingredient as Ranitidine 150 mg (as Ranitidine hydrochloride USP 168 mg). It includes batch number, manufacture date, expiration date, NDC number 62207-774-32, manufacturing license number 37/RR/AP/2003/F/R, and the quantity of 10,000 tablets. The label advises storage at 20°-25°C, avoiding excessive heat or humidity, and is labeled for repacking only. Country of origin: India. Labeler: Granules India Ltd.*
FDA Label Image

62207-774-336.jpg (62207 774 36)

62207-774-336.jpg (62207 774 36)
Label for Ranitidine tablets USP 150 mg Cool mint, film-coated oral tablets containing 150 mg of ranitidine (as ranitidine hydrochloride USP 168 mg). Label includes batch number, manufacturing and expiration dates (placeholders), NDC number 62207-774-36, manufacturing license number, quantity details of 5x10,000 units, weight specifications, storage instructions to avoid excessive heat or humidity, and caution for repackaging. Country of origin indicated as India, with barcode and product code included.*
FDA Label Image

62207 774 41 Carton

62207 774 41 Carton
The packaging label for Ranitidine cool mint presents Ranitidine Tablets, USP 150 mg in tablet form, designed as maximum strength acid reducers. The label specifies 24 tablets per package, mentions the cooling sensation benefit, and highlights relief from heartburn and acid indigestion. It includes the NDC 62207-774-41 and is labeled by Granules India Ltd. The label also contains detailed drug facts and usage instructions.*
FDA Label Image

62207 774 47 Carton

62207 774 47 Carton
The image shows a flat layout of the packaging label for Ranitidine cool mint 150 mg tablets by Granules India Ltd. The label states the product as maximum strength Ranitidine Tablets, USP, an acid reducer with a cooling sensation in mouth and throat. The package contains 500 tablets (500 doses). It includes drug facts, directions, warnings, inactive ingredients, and manufacturer and distributor information.*
FDA Label Image

62207 774 58 Carton

62207 774 58 Carton
Ranitidine cool mint 150 mg oral tablets packaging label. The front panel identifies the product as Ranitidine Tablets, USP 150 mg, an acid reducer for heartburn relief, in a carton containing 20 tablets (2 blister packs of 10). Labeler is Granules India Ltd. The label includes Drug Facts, usage instructions, warnings, and barcode.*
FDA Label Image

7aad3674 D678 5069 E053 2a91aa0a46f6

7aad3674 D678 5069 E053 2a91aa0a46f6
Text panel titled Ranitidine Tablets, USP 150 mg, lists each film coated tablet contains 150 mg Ranitidine (as Ranitidine hydrochloride USP 168 mg). Includes placeholders for Batch No., Manufacturing Date, Expiration Date, NDC No. 62207-773-32, and Manufacturing License No. 37/RR/AP/2003/F/R. States packaging contains 10,000 units, storage instructions to keep at 20-25°C (68-77°F) avoiding heat and humidity, caution for repacking only, and country of origin as India.*
FDA Label Image

Ranitidine 150mg Label1 Jpg

Ranitidine 150mg Label1 Jpg
Ranitidine cool mint 150 mg oral tablets packaging label for acid reduction. The label states the product prevents and relieves heartburn associated with acid indigestion and sour stomach. It includes drug facts, active ingredient details, manufacturer and distributor information (Granules India Ltd and Granules USA, Inc.), barcode, lot and expiration date sections. The label indicates 500 tablets (500 doses) per package.*
FDA Label Image

Ranitidine 150mg Label2 Jpg

Ranitidine 150mg Label2 Jpg
Ranitidine cool mint 150 mg oral tablets packaging label by Granules India Ltd. The label identifies the product as Ranitidine Tablets, USP, used as an acid reducer to prevent and relieve heartburn, providing a cooling sensation in mouth and throat. The label lists 500 tablets per package and includes drug facts, warnings, manufacturer and distributor information, barcode, lot and expiration date sections.*
FDA Label Image

Ranitidine Label3 Jpg

Ranitidine Label3 Jpg
Packaging label for Ranitidine cool mint tablets, USP 150 mg, an oral acid reducer by Granules India Ltd. The label includes the proprietary name, dosage strength, description as acid reducer, quantity of 24 tablets, directions, warnings, inactive ingredients, manufacturer and distributor information, drug facts, and bar code. The label dimensions and layout for print production are also shown.*
FDA Label Image

Ranitidine Label4 Jpg

Ranitidine Label4 Jpg
The image shows the full drug facts labeling for Ranitidine cool mint 150 mg oral tablets by Granules India Ltd. It includes active ingredients, purpose, uses, warnings, directions for use, inactive ingredients, and manufacturer information. Dosage, storage, and allergy alerts are also detailed across multiple text panels intended for consumer guidance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.